2015
DOI: 10.1186/s12911-015-0229-4
|View full text |Cite
|
Sign up to set email alerts
|

A clinical decision support tool to screen health records for contraindications to stroke thrombolysis–a pilot study

Abstract: BackgroundThe use of intravenous thrombolysis for stroke is limited by contraindications that may be difficult to identify promptly and accurately. Evidence supports the use of information technology-based clinical decision support (CDS) tools to achieve improvements in care delivery. The objective of this pilot study was to investigate the efficacy of a CDS tool to screen health records for contraindications to intravenous stroke thrombolysis.MethodsA CDS tool was developed to rapidly screen health informatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Of the research groups working on CDS in the stroke domain, some identify and display contraindications to thrombolysis at the point of care (5,6), whilst others focus on predicting outcomes in the case that thrombolysis is administered versus not administered (7)(8)(9). A recent review of machine learning methods for selecting patients who might benefit most from thrombolysis treatment is provided in (10).…”
Section: Existing Thrombolysis Cds Systems For Ehr Datamentioning
confidence: 99%
“…Of the research groups working on CDS in the stroke domain, some identify and display contraindications to thrombolysis at the point of care (5,6), whilst others focus on predicting outcomes in the case that thrombolysis is administered versus not administered (7)(8)(9). A recent review of machine learning methods for selecting patients who might benefit most from thrombolysis treatment is provided in (10).…”
Section: Existing Thrombolysis Cds Systems For Ehr Datamentioning
confidence: 99%
“…Academic research in Taiwan has contributed to CDSS development including AI-based CDSSs to screen for contraindications [34], predict medical conditions [35,36], recommend medications [37] and support diagnosis [15].…”
Section: Advancing Healthcare Withmentioning
confidence: 99%